3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
4
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
8
Anemia
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Neoplasms
7
Myelodysplastic Syndromes
7
Primary Myelofibrosis
5
Myeloproliferative Disorders
5
Lymphoma, Follicular
5
Leukemia
5
Hematologic Neoplasms
5
Anemia, Refractory, with Excess of Blasts
5
Thrombocytopenia
4
Polycythemia Vera
4
Lymphoma, Mantle-Cell
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Accelerated Phase
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Febrile Neutropenia
4
Congenital Abnormalities
4
Anemia, Sickle Cell
4
Anemia, Aplastic
4
Thrombocythemia, Essential
3
Pdgfra-Associated Chronic Eosinophilic Leukemia
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Leukemia, Neutrophilic, Chronic
3
Leukemia, Myelomonocytic, Chronic
3
Burkitt Lymphoma
3
Blast Crisis
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Severe Combined Immunodeficiency
×
Classical hematology
×
Clear all
NCT04331483
2022-02-28
EVAADE
Centre Leon Berard
Phase NA
Withdrawn